SPL
Click for more information
1.06% 9.5¢ starpharma holdings limited

Could this happen to Viraleze with marketing approval, page-24

  1. sarge17
    3,349 Posts.
    lightbulb Created with Sketch. 793
    clock Created with Sketch.
    21/04/24
    11:06
    Post #: 73442900
    ‘ignoring the reality of regulatory processes’ ~@Maz2024

    No not me, but someone did back in 2021...

    A former employee of Starpharma told Alan Kohler in a interview that TGA regulatory approval of Viraleze should only be a “matter of weeks’

    Still we wait.

    Was that ignoring reality as you put it?

    SPL Price at posting: 13.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ARU Arafura updates gas supply agreement with Mereenie JV for 16.4PJ supply to Nolans REE play
right-arrow Created with Sketch.
NVA Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
right-arrow Created with Sketch.
ABY Adore Beauty appoints former David Jones exec as new CEO
right-arrow Created with Sketch.
IDA Indiana Resources to win US$90M from Tanzania following international lawsuit
right-arrow Created with Sketch.
MTL Mantle Minerals' Nick Poll talks to HotCopper on finding gold grades up to 3.57g/t at Mt Berghaus
right-arrow Created with Sketch.
NEWS Super PITch gold sponsor RSM Australia: Can Diggers & Dealers 2024 be key to reinvigorating IPO activity?
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢ 		Change
0.001(1.06%) 		Mkt cap ! $38.76M
Open High Low Value Volume
9.4¢ 9.5¢ 9.4¢ $13.96K 147.5K

Buyers (Bids)

No. Vol. Price($)
3 238000 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.6¢ 5257 1
View Market Depth
Last trade - 11.38am 31/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.